
Humana Inc.
Humana Inc. (HUM) Free Cash Flow & Analysis
Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.
HUM · free cash flow · updated Jun 8, 2026
Core FCF metrics
HUM · FCF · TTM · margin & CAGRFree cash flow was $375.0M for FY2025 (fiscal year ending 2025-12-31), down 84.3% year-over-year The FCF margin was 0.3%. Five-year CAGR stands at -39.6%.
Annual free cash flow history
Annual free cash flow data
FCF valuation metrics
HUM · P/FCF · FCF yield · FCF per shareHumana Inc. (HUM) trades at a FCF yield of 3.00% and a price-to-free-cash-flow ratio of 33.3x. FCF per share stands at $10.56, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.
Cash flow statement summary
HUM · cash flow statement · operating / investing / financingFor FY2025, Humana Inc. generated $921.0M in operating cash flow and spent 546M in capital expenditures, yielding $375.0M in free cash flow.
For the complete Operating / Investing / Financing line-item breakdown:
View Full Cash Flow Statement →Free cash flow vs peers (Healthcare)
About Free Cash Flow & Methodology
Humana Inc. (HUM) reported free cash flow of $375.0M for FY2025 (fiscal year ending 2025-12-31), down 84.3% year-over-year. The FCF margin was 0.3%.
Based on available data, Humana Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $4.67B in FY2020. The 5-year CAGR stands at -39.6%.
Humana Inc.'s FCF yield is 3.00% and price-to-FCF ratio is 33.3x for FY2025, based on the latest available data.
Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.
Frequently asked questions
HUM free cash flow · 8 questionsHumana Inc. free cash flow was $375.0M for FY2025, down 84.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.27B.
▸ Source: FMP /cash-flow-statement · US GAAP · Humana Inc. · Humana Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026